pre-IPO PHARMA

COMPANY OVERVIEW

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.


LOCATION

  • Boston, MA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.curelaboncology.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Jul 20, 2021

    CureLab Oncology Granted US Patent for Therapeutic Use of its Lead Product in ALS, Alzheimer's, Huntington's, and Parkinson's Diseases


    Jan 21, 2021

    Curelab Veterinary Launches in Animal Health Sector, Leveraging Technology Licensed from CureLab Oncology


    Oct 21, 2020

    CureLab Oncology Establishes Operations in the Gulf Region USA - English Middle East - English


    Oct 14, 2020

    CureLab Oncology Appoints The Honorable David J. Shulkin, M.D. to its Scientific Advisory Board


    Oct 2, 2018

    CureLab Oncology publishes proof of concept demonstrating that its product can reduce the leading cause of age-related blindness


    For More Press Releases


    Google Analytics Alternative